Characterization of the cytotoxic activities of novel analogues of the antitumor agent, lavendamycin.

Fang, Yanan; Linardic, Corinne M; Richardson, D Ashley; Cai, Wen; Behforouz, Mohammad; Abraham, Robert T

Fang, Yanan; Linardic, Corinne M; Richardson, D Ashley; Cai, Wen; Behforouz, Mohammad; Abraham, Robert T.

Affiliation

Fang Y; Department of Pharmacology and Cancer Biology, Duke University, Durham, North Carolina 27710, USA.

Mol Cancer Ther ; 2(6): 517-26, 2003 Jun.

Article in En | MEDLINE | ID: mdl-12813130

Subject(s)

Antineoplastic Agents/pharmacology; Streptonigrin/analogs & derivatives; Streptonigrin/pharmacology; Apoptosis; Cell Cycle; Cell Line, Tumor; Flow Cytometry; G2 Phase; Humans; Immunoblotting; Mitosis; Models, Chemical; Phosphorylation; Proto-Oncogene Proteins p21(ras)/biosynthesis; Streptonigrin/chemistry; Time Factors; Tumor Suppressor Protein p53/biosynthesis

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Streptonigrin / Antineoplastic Agents Type of study: Prognostic_studies Limits: Humans Language: En Journal: Mol Cancer Ther Journal subject: ANTINEOPLASICOS Year: 2003 Document type: Article Affiliation country: United States Country of publication: United States

Search on Google

Add to My VHL

XML

PubMed Links